NEW YORK – A team from Weill Cornell Medicine, the Broad Institute, Dana-Farber Cancer Institute, and elsewhere has identified a handful of new complex genome rearrangement groups in cancer genomes using a junction balance-based analysis focused on thousands of available tumor genome sequences.